Cargando…
An enhanced antioxidant strategy of astaxanthin encapsulated in ROS-responsive nanoparticles for combating cisplatin-induced ototoxicity
BACKGROUND: Excessive accumulation of reactive oxygen species (ROS) has been documented as the crucial cellular mechanism of cisplatin-induced ototoxicity. However, numerous antioxidants have failed in clinical studies partly due to inefficient drug delivery to the cochlea. A drug delivery system is...
Autores principales: | Gu, Jiayi, Wang, Xueling, Chen, Yuming, Xu, Ke, Yu, Dehong, Wu, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185887/ https://www.ncbi.nlm.nih.gov/pubmed/35689218 http://dx.doi.org/10.1186/s12951-022-01485-8 |
Ejemplares similares
-
Current Strategies to Combat Cisplatin-Induced Ototoxicity
por: Yu, Dehong, et al.
Publicado: (2020) -
Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity
por: Chen, Yuming, et al.
Publicado: (2019) -
Astaxanthin-loaded polymer-lipid hybrid nanoparticles (ATX-LPN): assessment of potential otoprotective effects
por: Gu, Jiayi, et al.
Publicado: (2020) -
Correction to: Astaxanthin-loaded polymer-lipid hybrid nanoparticles (ATX-LPN): assessment of potential otoprotective effects
por: Gu, Jiayi, et al.
Publicado: (2020) -
Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo
por: Nan, Benyu, et al.
Publicado: (2022)